Our Model

At Formation Bio we acquire promising clinical-stage drug candidates and develop them in house. We bring together best in class talent from the pharma and technology industries, combining sophisticated development strategy with proprietary technology and AI capabilities that can power hyper-efficient drug development.

Partners

Pharma

Biotech

Universities

Formation Bio Drug
development Platform

Bespoke Exit Pathways

How We Operate

01

Acquire drug assets

Acquire clinical-stage drugs in a variety of therapeutic areas

02

Develop drugs in-house

Leverage development engine to uniquely develop drugs faster and maximize value

03

Realize value inflection points

Realize increased value through bespoke exit and development pathways

Drug Development Platform

Formation Bio is an end-to-end drug developer that leverages its proprietary tech-driven platform to develop drugs faster and more efficiently, unlocking greater value per program and accelerating access to new treatments for patients.

  • 01
    Research and development

    Our teams and advisors have worked on 45+ approved drugs, and bring deep cross-functional expertise across all elements of drug development.

  • 02
    Clinical operations

    Our trials are run in-house by our top tier clinical operations functions, including patient recruitment, site management, and study monitoring.

  • 03
    Technology

    All of our platforms are supported by our integrated tech platform, including patient intelligence, data surveillance, and a universal data layer.

Advantages of our Model

Formation Bio’s end-to-end tech-driven drug development platform optimizes all aspects of the drug development lifecycle, with core competitive advantages across:

  • Faster drug development through proprietary tech-driven platform
  • Best in class team across drug selection, drug development, and tech
  • Flexible structures and financing pathways

Partner With Us

Interested in learning more about our approach?

© Formation Bio 2024
Site Credit